BIYKEM BOZKURT to Receptors, Tumor Necrosis Factor
This is a "connection" page, showing publications BIYKEM BOZKURT has written about Receptors, Tumor Necrosis Factor.
Connection Strength
0.236
-
Results of targeted anti-tumor necrosis factor therapy with etanercept (ENBREL) in patients with advanced heart failure. Circulation. 2001 Feb 27; 103(8):1044-7.
Score: 0.169
-
Safety and efficacy of a soluble P75 tumor necrosis factor receptor (Enbrel, etanercept) in patients with advanced heart failure. Circulation. 1999 Jun 29; 99(25):3224-6.
Score: 0.038
-
Effect of the soluble TNF-antagonist etanercept on tumor necrosis factor bioactivity and stability. Clin Transl Sci. 2008 Sep; 1(2):142-5.
Score: 0.018
-
Plasma matrix metalloproteinase and inhibitor profiles in patients with heart failure. J Card Fail. 2002 Dec; 8(6):390-8.
Score: 0.012